Literature DB >> 19888051

Stillbirth classification--developing an international consensus for research: executive summary of a National Institute of Child Health and Human Development workshop.

Uma M Reddy1, Robert Goldenberg, Robert Silver, Gordon C S Smith, Richard M Pauli, Ronald J Wapner, Jason Gardosi, Halit Pinar, Marjorie Grafe, Michael Kupferminc, Ingela Hulthén Varli, Jan Jaap H M Erwich, Ruth C Fretts, Marian Willinger.   

Abstract

Stillbirth is a major obstetric complication, with 3.2 million stillbirths worldwide and 26,000 stillbirths in the United States every year. The Eunice Kennedy Shriver National Institute of Child Health and Human Development held a workshop from October 22-24, 2007, to review the pathophysiology of conditions underlying stillbirth to define causes of death. The optimal classification system would identify the pathophysiologic entity initiating the chain of events that irreversibly led to death. Because the integrity of the classification is based on available pathologic, clinical, and diagnostic data, experts emphasized that a complete stillbirth workup should be performed. Experts developed evidence-based characteristics of maternal, fetal, and placental conditions to attribute a condition as a cause of stillbirth. These conditions include infection, maternal medical conditions, antiphospholipid syndrome, heritable thrombophilias, red cell alloimmunization, platelet alloimmunization, congenital malformations, chromosomal abnormalities including confined placental mosaicism, fetomaternal hemorrhage, placental and umbilical cord abnormalities including vasa previa and placental abruption, complications of multifetal gestation, and uterine complications. In all cases, owing to lack of sufficient knowledge about disease states and normal development, there will be a degree of uncertainty regarding whether a specific condition was indeed the cause of death.

Entities:  

Mesh:

Year:  2009        PMID: 19888051      PMCID: PMC2792738          DOI: 10.1097/AOG.0b013e3181b8f6e4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  69 in total

Review 1.  Intrauterine subdural hemorrhage.

Authors:  C I Akman; J Cracco
Journal:  Dev Med Child Neurol       Date:  2000-12       Impact factor: 5.449

2.  MECHANISMS OF ISOIMMUNIZATION. I. THE TRANSPLACENTAL PASSAGE OF FETAL ERYTHROCYTES IN HOMOSPECIFIC PREGNANCIES.

Authors:  F COHEN; W W ZUELZER; D C GUSTAFSON; M M EVANS
Journal:  Blood       Date:  1964-05       Impact factor: 22.113

Review 3.  Acute fatty liver of pregnancy.

Authors:  H Ko; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

4.  The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study.

Authors:  Liesbeth Lewi; Jacques Jani; Isaac Blickstein; Agnes Huber; Leonardo Gucciardo; Tim Van Mieghem; Elisa Doné; Anne-Sophie Boes; Kurt Hecher; Eduardo Gratacós; Paul Lewi; Jan Deprest
Journal:  Am J Obstet Gynecol       Date:  2008-06-04       Impact factor: 8.661

5.  Do placental weights have clinical significance?

Authors:  R L Naeye
Journal:  Hum Pathol       Date:  1987-04       Impact factor: 3.466

6.  The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification.

Authors:  J N Martin; B K Rinehart; W L May; E F Magann; D A Terrone; P G Blake
Journal:  Am J Obstet Gynecol       Date:  1999-06       Impact factor: 8.661

7.  Placental abruption and adverse perinatal outcomes.

Authors:  C V Ananth; G S Berkowitz; D A Savitz; R H Lapinski
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

Review 8.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.

Authors:  M Empson; M Lassere; J Craig; J Scott
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 9.  Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals.

Authors:  R M Pauli; C A Reiser
Journal:  Am J Med Genet       Date:  1994-04-01

Review 10.  Trisomy 16 and trisomy 16 Mosaicism: a review.

Authors:  P Benn
Journal:  Am J Med Genet       Date:  1998-09-01
View more
  29 in total

1.  An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Adi L Tarca; Maria Teresa Gervasi; Juan Pedro Kusanovic; Pooja Mittal; Giovanna Ogge; Edi Vaisbuch; Shali Mazaki-Tovi; Zhong Dong; Sun Kwon Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-12

2.  Evaluation of an active surveillance system for stillbirths in metropolitan Atlanta.

Authors:  Alejandro Azofeifa; Lorraine F Yeung; C Wes Duke; Suzanne M Gilboa; Adolfo Correa
Journal:  J Registry Manag       Date:  2012

3.  The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Offer Erez; Adi L Tarca; Agustin Conde-Agudelo; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  Am J Obstet Gynecol       Date:  2017-10-13       Impact factor: 8.661

4.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

Review 5.  Challenges in classification and assignment of causes of stillbirths in low- and lower middle-income countries.

Authors:  Jacquelyn K Patterson; Aleha Aziz; Melissa S Bauserman; Elizabeth M McClure; Robert L Goldenberg; Carl L Bose
Journal:  Semin Perinatol       Date:  2019-03-16       Impact factor: 3.300

6.  Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Yi Xu; Faisal Qureshi; Suzanne Jacques; Wonsuk Yoo; Tinnakorn Chaiworapongsa; Pooja Mittal; Sonia S Hassan; Chong Jai Kim
Journal:  Histopathology       Date:  2011-11       Impact factor: 5.087

7.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

8.  Global report on preterm birth and stillbirth (2 of 7): discovery science.

Authors:  Michael G Gravett; Craig E Rubens; Toni M Nunes
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

9.  Chromosome preparation from cultured cells.

Authors:  Bradley Howe; Ayesha Umrigar; Fern Tsien
Journal:  J Vis Exp       Date:  2014-01-28       Impact factor: 1.355

10.  Intrauterine fetal demise can be remote from the inciting insult in an animal model of hypoxia-ischemia.

Authors:  Matthew Derrick; Ila Englof; Alexander Drobyshevsky; Kehuan Luo; Lei Yu; Sidhartha Tan
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.